Zogenix, Inc.
(NASDAQ : ZGNX)

( )
ZGNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.32%18.391.8%$132.24m
ICPTIntercept Pharmaceuticals, Inc.
4.05%90.5318.6%$94.99m
SAGESAGE Therapeutics, Inc.
0.89%166.988.8%$82.15m
JAZZJazz Pharmaceuticals Plc
3.03%129.782.3%$71.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.21%165.566.3%$60.71m
PRGOPerrigo Co. Plc
1.21%49.566.8%$54.61m
ZGNXZogenix, Inc.
0.48%37.399.9%$45.65m
UTHRUnited Therapeutics Corporation
5.53%104.3114.3%$44.47m
CTLTCatalent Inc
0.91%44.442.4%$39.76m
HZNPHorizon Pharma plc
2.98%25.266.7%$35.55m
PTLAPortola Pharmaceuticals, Inc.
2.76%35.407.6%$33.06m
ICLRICON Plc
3.89%135.054.1%$30.66m
ZYNEZynerba Pharmaceuticals Inc
4.21%9.908.3%$28.70m
MYOKMyoKardia, Inc.
2.06%49.072.4%$25.77m
MNKMallinckrodt Plc
3.15%18.3621.0%$25.24m

Company Profile

Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.